Company intelligence / Profile preview
PeriFlow Therapeutics
Boston, MA, United Statesperiflowtx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PeriFlow Therapeutics is a Boston-based biotechnology company focused on developing first-in-class treatments for pathological hypercontraction and capillary no-reflow (CNR) conditions. The company's lead program, CLN-2501, is a selective smooth muscle myosin inhibitor designed to restore capillary blood flow after acute myocardial infarction (AMI). Beyond cardiac ischemia, PeriFlow is building a portfolio of highly selective myosin inhibitors targeting pathological hypercontraction in other indications, including acute kidney injury, ischemic stroke, and organ transplantation. Founded by researchers from the Eötvös Loránd University spinoff Motorpharma, the company is currently advancing its lead candidate toward clinical development in the United States.
- Therapeutic areas
- ImmunologyCardiovascularNephrology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Motorpharma
Beyond the preview
Go deeper on PeriFlow Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PeriFlow Therapeutics.